Avantax Advisory Services’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-314
| Closed | -$4K | – | 1467 |
|
|
2022
Q3 | $4K | Hold |
314
| – | – | ﹤0.01% | 1325 |
|
|
2022
Q2 | $11K | Hold |
314
| – | – | ﹤0.01% | 1296 |
|
|
2022
Q1 | $13K | Sell |
314
-457
| -59% | -$18.9K | ﹤0.01% | 1274 |
|
|
2021
Q4 | $33K | Buy |
771
+314
| +69% | +$13.4K | ﹤0.01% | 1236 |
|
|
2021
Q3 | $31K | Hold |
457
| – | – | ﹤0.01% | 1167 |
|
|
2021
Q2 | $35K | Buy |
+457
| New | +$35K | ﹤0.01% | 1130 |
|
|
2020
Q3 | – | Sell |
-243
| Closed | -$9K | – | 1400 |
|
|
2020
Q2 | $9K | Hold |
243
| – | – | ﹤0.01% | 851 |
|
|
2020
Q1 | $6K | Hold |
243
| – | – | ﹤0.01% | 801 |
|
|
2019
Q4 | $12K | Buy |
243
+100
| +70% | +$4.94K | ﹤0.01% | 827 |
|
|
2019
Q3 | $7K | Buy |
+143
| New | +$7K | ﹤0.01% | 566 |
|